Eden Lake is a Dermatology physician affiliated with NorthShore University HealthSystem. OpenAlex indexes 85 publications with 204 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
321 N La Grange Rd
La Grange Park, IL 605265622
Telephone
708-485-1271Provider last certified this registry record 19 Apr 2021.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20254 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20257 payments
- ABBVIE INC.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
26.3%Azole Antifungal15.7%Ketoconazole100%Part D≥72 patientsTetracycline-class Drug5.4%Doxycycline Hyclate100%Part D≥24 patients+ 2 more classes in this area
Dermatology
26.2%Corticosteroid23%Triamcinolone Acetonide100%Part D≥123 patientsPolyene Antifungal1.7%Nystatin100%Part D<11 patients+ 1 more class in this area
Sensory organs
21.4%Corticosteroid19.6%Clobetasol Propionate63%Hydrocortisone30%Betamethasone Dipropionate7%Part D<11 patientsAminoglycoside Antibacterial1.8%Gentamicin Sulfate100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- JAAD Game Changers: Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: A multicenter retrospective cohort study
Journal of the American Academy of Dermatology
2025 - JAAD Game Changers: Melanoma survival by age group: Population-based disparities for adolescent and young adult patients by stage, tumor thickness, and insurance type
Journal of the American Academy of Dermatology
2025 - Blau Syndrome With Delayed Cutaneous Manifestations: A Case Report
American Journal of Dermatopathology
2024 - JAAD Game Changers: Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy
Journal of the American Academy of Dermatology
2024 - JAAD Game Changer: Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Jack Singer, MD
NorthShore University HealthSystem
Julian Bailes, MD
NorthShore University HealthSystem
Peter Sand, MD
NorthShore University HealthSystem
Mark Talamonti, MD
NorthShore University HealthSystem
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”